ALDH1A2 and lung cancer: Controversially, an in vitro study showed that K562 leukemia and H1299 lung cancer cell with ALDH1A2 overexpression exhibited higher cell proliferation rates, higher clonal efficiency, and increased drug resistance to 4-hydroperoxycyclophosphamide and doxorubicin [33].